Searched for
NOVO NORDISK MARKET LEADER
EU officials fear leaders will balk in confronting ChinaDespite acknowledging severe stakes, leaders struggle to agree on tangible steps to address a massive trade deficit and Chinese state subsi...- Robust overseas show helps TVS emerge top 2-wheeler company in IndiaTVS Motor Company has achieved a significant milestone, becoming India's largest two-wheeler manufacturer by total monthly sales for the fi...
- AIADMK faces fresh setback as senior leaders join TVKProminent AIADMK figures, including former ministers C Vijayabaskar and MR Vijayabhaskar, have defected to Chief Minister C Vijay Joseph's ...
- Maruti Suzuki's Kharkhoda facility inaugurated by PM Modi, Japanese PM Sanae TakaichiPrime Minister Narendra Modi and Japanese counterpart Sanae Takaichi virtually inaugurated Maruti Suzuki's advanced fourth manufacturing fa...
- Microsoft launches firm to help companies adopt AI with $2.5 billionMicrosoft has launched a new venture, Microsoft Frontier Company, backed by $2.5 billion, to guide businesses in selecting and integrating ...
- Medical device maker Zimmer Biomet to hire 500 employees in 3 years for tech centre in IndiaMedical device giant Zimmer Biomet is set to significantly expand its Indian footprint by hiring 500 professionals over three years for its...
- Shantha Biologics to Make Injectable Drug Cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...
- Blinkit to remain undisputed market leader despite Amazon, Flipkart's QC entry, says Anand Rathi, sees 43% upsideDespite concerns over Amazon and Flipkart intensifying competition in India's quick commerce market, Anand Rathi believes Blinkit remains t...
- Waaree Energies shares crash 5%. Can this US ruling dent solar panel maker's image for long?Waaree Energies shares fell nearly 5% after a US Customs ruling triggered concerns over reputational impact despite the company’s clarifica...
- Elon Musk says Grok 4.5 is now in private beta, claims performance near or above Anthropic's OpusMusk said reinforcement learning is continuing to improve the model and that "Grok Build," xAI's coding-agent harness, is being refined dai...
- India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
- Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
- Bombay HC cancels 'Duphachrit' trademark, rules it deceptively similar to Abbott's 'Dupha' familyThe Bombay High Court has cancelled Thane-based Menschlich Healthcare's trademark 'Duphachrit' in favour of Abbott Product Operations AG. T...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- European shares rally as Middle East peace hopes drag oil prices lowerEuropean shares surged on Friday, driven by renewed hopes for a Middle East diplomatic breakthrough that lowered oil prices. The pan-Europe...
- Global Market | European stocks rally as oil falls on hopes for US-Iran dealThe benchmark snapped a four-day losing streak on Thursday, as investors digested the European Central Bank's rate hike and largely looked...
- UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...
- Novo Nordisk hit by cyber incident, probes data breachDanish drugmaker Novo Nordisk has confirmed a security incident. Unauthorised access to internal IT systems occurred. Certain non-public da...
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
- US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...
Load More
